🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This pilot study will attempt to establish the feasibility of using tissue ...
Status
Completed
Location
Dartmouth-Hitchcock Medical Center in Lebanon, NH
Start Date
2018-03-01
Trial ID
NCT03348956
Treatments Being Tested
The purpose of the protocol is to achieve an in-depth understanding of the ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-02-13
Trial ID
NCT05184231
The goal of this clinical research study is to learn if temozolomide alone ...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2006-08
Trial ID
NCT00525031
Treatments Being Tested
This is a phase II open-label study evaluating the pharmacokinetics and pha...
Status
Withdrawn
Location
St. Boniface General Hospital Research Centre
Start Date
2020-01
Trial ID
NCT04025177
Treatments Being Tested
This prospective observational study aims to evaluate the efficacy, safety ...
Status
Unknown
Location
Endoscopy Unit, Gastroenterology Department, Humanitas Research Hospital
Start Date
2024-07-01
Trial ID
NCT06435377
Treatments Being Tested
Indocyanine Green (ICG) is a dye which fluoresces under near-infrared (NIR)...
Status
Completed
Location
Birmingham children's hospital
Start Date
2023-02-01
Trial ID
NCT05735977
Treatments Being Tested
Platelet-Rich Plasma (PRP) has been banned in competitive athletes because ...
Status
Completed
Location
New York University Langone Orthopedic Hospital
Start Date
2010-07
Trial ID
NCT01200875
Treatments Being Tested
This Phase I study is to investigate the safety of two dose levels of NFL-1...
Status
Completed
Location
Institut du Cancer de Montpellier - Val d'Aurelle
Start Date
2014-12
Trial ID
NCT02521701
Treatments Being Tested
This is a single arm, open label study of up to 24 high risk prostate cance...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2012-01
Trial ID
NCT01572701
Treatments Being Tested
This is a multicenter, phase 2, open label study to evaluate safety, tolera...
Status
Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2025-09-05
Trial ID
NCT07102901
Treatments Being Tested